Related Experiment Video
Updated: May 1, 2026

Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Growth without growth hormone: growth pattern and final height of five patients with idiopathic combined pituitary
Liora Lazar1, Sivan Dan, Moshe Phillip
1Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva and Faculty of Medicine, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Insights
Children with idiopathic combined pituitary hormone deficiency (CPHD) can achieve normal final height despite persistent growth hormone deficiency (GHD). This unexpected growth suggests other factors may influence height attainment in these patients.
Area of Science:
- Pediatric Endocrinology
- Growth Hormone Research
- Hormone Deficiency Studies
Background:
- Combined Pituitary Hormone Deficiency (CPHD) can impact growth, particularly when growth hormone (GH) is deficient.
- Previous cases of growth without GH have been observed in specific conditions like craniopharyngiomas, hypothalamic tumors, and septo-optic dysplasia.
Observation:
- This study focused on five children with idiopathic CPHD (GH, TSH, ACTH, LH, FSH) who exhibited normal growth despite continuous GH deficiency.
- Clinical observations included borderline small penis in two children and absent pubertal signs in three adolescents, who also displayed acromegaloid features.
- Patients maintained heights within the 10-25th percentiles and weights within the 25-50th percentiles, with a prepubertal growth rate of 4-5 cm/year.
Findings:
- Despite persistent GH deficiency, all patients achieved final heights within or exceeding their target range (boys: 170-179 cm; girl: 164 cm) at an advanced age (19-22 years).
- Pubertal growth was delayed and reduced, occurring after sex hormone therapy initiation, with a total pubertal growth of 6-11.7 cm.
- Hormonal evaluations consistently showed undetectable GH and IGF-I levels, with no evidence of hyperprolactinemia or hyperinsulinism.
Implications:
- Unexpected final height attainment in idiopathic CPHD patients with GH deficiency suggests the involvement of unidentified growth-promoting factors.
- Further research is needed to elucidate the mechanisms behind this non-GH-mediated growth.
- Understanding these alternative pathways could lead to new therapeutic strategies for growth disorders.
Background:
Growth without GH has been reported in patients with organic combined pituitary hormone deficiency (CPHD) after resection of craniopharyngiomas and hypothalamic tumours or in septo-optic dysplasia.
Methods:
This study describes the growth pattern and final height of five children (four boys, one girl) with idiopathic CPHD (GH, TSH, ACTH, LH and FSH) who maintained normal growth despite persistent GH deficiency throughout the growth period.
Results:
Presenting findings were borderline small penis in two children diagnosed at ages 3 and 9 years, and absence of pubertal signs in three adolescents diagnosed at age 12.8-13.7 years. The latter three patients also exhibited acromegaloid features. The height of all patients was within the 10-25th percentiles, and weight at the 25-50th percentiles. Although they were moderately overweight, accelerated weight gain was not observed. Prepubertal growth rate was 4-5 cm/year. The pubertal growth period, starting after initiation of sex hormone therapy (chronological age 15.9-16.3 years and bone age 12.5-14.5 years) continued for 4-5.5 years. Total pubertal growth was 6-11.7 cm with reduced growth spurt. Final height, which was attained at an advanced age (19-22 years), was 170-179 cm in the boys and 164 cm in the girl, equal to or exceeding the target height range. Repeated hormonal evaluations revealed undetectable GH and IGF-I levels, and no evidence of hyperprolactinaemia or hyperinsulinism.
Conclusions:
Final height attainment within or above target height range may occur in patients with idiopathic CPHD despite persistent GHD. As this was not mediated by GH, IGF-I, insulin or prolactin, some other growth factors probably played a growth-promoting role.
More Related Videos
09:48Development of Organoids from Mouse Pituitary as In Vitro Model to Explore Pituitary Stem Cell Biology
Published on: February 25, 2022
08:03Midface Hypoplasia and Cranial Base Morphology in Syndromic Craniosynostosis: A Comparative Analysis Study Using a Predictive Regression Model
Published on: November 4, 2025
Related Concept Videos
Polygenic Traits
Nature and Nurture
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones of the Pituitary Gland
The most abundantly secreted hormone from the anterior lobe is the growth hormone, which controls overall growth by...
Signs of Puberty
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...